Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study Assessment of Bone Mineral Density Changes During Treatment With Anti-PD-1 Immunotherapy Agents

NCT07555210 is registered in ClinicalTrials.gov with Jessica Mezzanotte Sharpe as lead sponsor.

NCT NCT07555210
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07555210 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study Assessment of Bone Mineral Density Changes During Treatment With Anti-PD-1 Immunotherapy Agents
Lead sponsor
Jessica Mezzanotte Sharpe
Phase
Not applicable
Overall status
Recruiting
Start date
August 25, 2025
Completion date
July 1, 2028
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer (triple negative breast cancer (tnbc)), classic hodgkin lymphoma, invasive mammary carcinoma, melanoma (skin cancer), msi-h/dmmr rectal cancer, non-small cell lung cancer, renal cell carcinoma (kidney cancer), squamous cell carcinoma mouth